Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine

by Simon eZhornitsky, Emmanuel eStip, Joelle eDesfosses, Tania ePampoulova, Elie eRizkallah, Elie eRizkallah, Pierre-Paul eRompre, Lahcen Ait Bentaleb, Olivier eLipp, Jean-Pierre eChiasson, Alain eGendron, Stephane ePotvin
Published 2011-05-01

A randomized-controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia

by Emmanuel eStip, Emmanuel eStip, Emmanuel eStip, Philippe D. Vincent, Philippe D. Vincent, Philippe D. Vincent, Catherine eGuevremont, Simon eZhornitsky, Constantin eTranulis, Constantin eTranulis, Constantin eTranulis, Juliette eSablier, Juliette eSablier
Published 2013-08-01